Core Viewpoint - Ningbo Tianyi Medical Instrument Co., Ltd. has announced a change in the use of raised funds, terminating the original project for the "Comprehensive R&D Center Construction Project" and reallocating the remaining funds to the new "Thailand Production Base Construction Project" [1][2]. Fundraising Basic Information - The company raised a total of RMB 771.77 million by issuing 14.7368 million shares at RMB 52.37 per share, with net proceeds amounting to RMB 694.56 million after deducting various fees [1]. - The funds were verified by Lixin Accounting Firm, which issued a verification report [1]. Fundraising Special Account and Supervision Agreement - The company has established a special fundraising account at Shanghai Pudong Development Bank, Ningbo High-tech Zone Branch, for the new project [2][3]. - The company has signed a tripartite supervision agreement with the bank and its sponsor, Guotai Junan Securities, to oversee the use of the raised funds [3][4]. Tripartite Supervision Agreement Key Points - The special accounts for RMB and USD have been established, with balances of RMB 108.29 million and USD 0 as of July 2, 2025 [4]. - The funds in these accounts are exclusively for the "Thailand Production Base Construction Project" and cannot be used for other purposes [4]. - The sponsor has the right to supervise the use of funds and can conduct on-site investigations and inquiries [5][6]. - Any withdrawal exceeding RMB 20 million within a 12-month period must be reported to the sponsor [6].
宁波天益医疗器械股份有限公司关于开立募集资金专项账户并签署募集资金三方监管协议的公告